Nuo Cheng

Dr. Nuo Cheng

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
YLYuwen Li
Yuwen Li
XMXiaodan Ma
Xiaodan Ma
ZCZhiming Chen
Zhiming Chen
HWHaiyan Wu
Haiyan Wu
PWPengran Wang
Pengran Wang
GMGuoyu Meng
Guoyu Meng
ProMyelocyticLeukemia (PML) protein can polymerize into a mega-Dalton nuclear assembly of 0.1–2 μm in diameter. The mechanism of PML nuclear body biogenesis remains elusive. Here, PMLRBCC is successfully purified. The gel filtration and ultracentrifugation analysis suggest a previously unrecognized sequential oligomerization mechanism via PML monomer, dimer, tetramer and N-mer. Consistently, PML B1-box structure (2.0 Å) and SAXS characterization reveal an unexpected networking by W157-, F158- and SD1-interfaces. Structure-based perturbations in these B1 interfaces not only impair oligomerization in vitro but also abolish PML sumoylation and nuclear body biogenesis in HeLaPml-/- cell. More importantly, as demonstrated by in vivo study using transgenic mice, PML-RARα (PR) F158E precludes leukemogenesis. In addition, single cell RNA sequencing analysis shows that B1 oligomerization is an important regulator in PML-RARα-driven transactivation. Altogether, these results not only define a previously unrecognized B1-box oligomerization in PML, but also highlight oligomerization as an important factor in carcinogenesis.

22 September 2022 in Blood
Verified
Journal Article
Open access
PDF file
MZMing Zhang
Ming Zhang
HZHao Zhang
Hao Zhang
ZLZhihui Li
Zhihui Li
LBLing Bai
Ling Bai
QWQianqian Wang
Qianqian Wang
SCSai-Juan Chen
Sai-Juan Chen
Recurrent MEF2D fusions with poor prognosis have been identified in B-cell precursor ALL (BCP-ALL). The molecular mechanisms underlying the pathogenic function of MEF2D fusions are poorly understood. Here, we show that MEF2D-HNRNPUL1 (MH) knock-in mice developed a progressive disease from impaired B-cell development at the pre–pro-B stage to pre-leukemia over 10 to 12 months. When cooperating with NRASG12D, MH drove an outbreak of BCP-ALL, with a more aggressive phenotype than the NRASG12D-induced leukemia. RNA-sequencing identified key networks involved in disease mechanisms. In chromatin immunoprecipitation–sequencing experiments, MH acquired increased chromatin-binding ability, mostly through MEF2D-responsive element (MRE) motifs in target genes, compared with wild-type MEF2D. Using X-ray crystallography, the MEF2D-MRE complex was characterized in atomic resolution, whereas disrupting the MH-DNA interaction alleviated the aberrant target gene expression and the B-cell differentiation arrest. The C-terminal moiety (HNRNPUL1 part) of MH was proven to contribute to the fusion protein’s trans-regulatory activity, cofactor recruitment, and homodimerization. Furthermore, targeting MH-driven transactivation of the HDAC family by using the histone deacetylase inhibitor panobinostat in combination with chemotherapy improved the overall survival of MH/NRASG12D BCP-ALL mice. Altogether, these results not only highlight MH as an important driver in leukemogenesis but also provoke targeted intervention against BCP-ALL with MEF2D fusions.

20 January 2026 in Science Signaling
Verified
Journal Article
Open access
KMKatie E. Mulholland
Katie E. Mulholland
MBMaxime Bourguet
Maxime Bourguet
NCNuo Cheng
Nuo Cheng
OROisharja Rahman
Oisharja Rahman
DEDaria Ezeriņa
Daria Ezeriņa
HSHayley J. Sharpe
Hayley J. Sharpe
Dynamic regulation of protein tyrosine phosphorylation (pTyr) by kinases and phosphatases enables cells to sense and respond to environmental changes. The widely used chemical pervanadate induces the accumulation of pTyr in mammalian cell lines. This effect is primarily attributed to its inhibition of protein tyrosine phosphatases (PTPs), leading to the assertion that PTPs are master gatekeepers of intracellular pTyr homeostasis. Here, we used several approaches to reveal that pervanadate disrupted cellular redox homeostasis and directly activated tyrosine kinases of the SRC family through the oxidation of specific cysteine residues. Mass spectrometry and biophysical approaches showed that pervanadate-induced oxidation of cysteine-188 and cysteine-280 activated SRC by disrupting autoinhibitory intramolecular interactions between the catalytic domain and the SH2/SH3 domains and by impairing SH2 domain binding to phosphopeptides, including the regulatory carboxyl-terminal tail phosphotyrosine-530. Redox-sensitive cysteine residues were essential for SRC to promote the overgrowth of mouse fibroblasts. Our findings call for a reevaluation of pervanadate-based experiments and demonstrate that SRC cysteines control its oncogenic properties.

12 October 2018 in Leukemia
Verified
Journal Article
Open access
PDF file
XDXue Dong
Xue Dong
HZHao Zhang
Hao Zhang
NCNuo Cheng
Nuo Cheng
KLKening Li
Kening Li
GMGuoyu Meng
Guoyu Meng

1 March 2021 in Protein Expression and Purification
Verified
Journal Article
Closed access
ZCZhiming Chen
Zhiming Chen
QWQianqian Wang
Qianqian Wang
HZHao Zhang
Hao Zhang
XMXiaodan Ma
Xiaodan Ma
WWWenyu Wu
Wenyu Wu
GMGuoyu Meng
Guoyu Meng

31 March 2021 in Acta Crystallographica Section F Structural Biology Communications
Verified
Journal Article
Closed access
PDF file
NCNuo Cheng
Nuo Cheng
HZHao Zhang
Hao Zhang
SZShiyan Zhang
Shiyan Zhang
XMXiaodan Ma
Xiaodan Ma
GMGuoyu Meng
Guoyu Meng